MX370585B - Proceso para preparar una composicion anti-helmintica, composicion anti-helmintica, metodo de tratamiento veterinario y metodo de tratamiento anti-helmintico. - Google Patents
Proceso para preparar una composicion anti-helmintica, composicion anti-helmintica, metodo de tratamiento veterinario y metodo de tratamiento anti-helmintico.Info
- Publication number
- MX370585B MX370585B MX2016007309A MX2016007309A MX370585B MX 370585 B MX370585 B MX 370585B MX 2016007309 A MX2016007309 A MX 2016007309A MX 2016007309 A MX2016007309 A MX 2016007309A MX 370585 B MX370585 B MX 370585B
- Authority
- MX
- Mexico
- Prior art keywords
- anthelmintic
- treatment method
- composition
- preparing
- anthelmintic composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a una composición anti-helmíntica inyectable de avermectina y sulfóxido de Albendazol base para usarse en el combate de parásitos que atacan animales; la invención contempla, aún, un proceso específico que permite la asociación estable de avermectina y sulfóxido de albendazol base.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102013031277A BR102013031277B1 (pt) | 2013-12-05 | 2013-12-05 | processo para preparar uma suspensão anti-helmíntica e suspensão anti-helmíntica injetável |
PCT/BR2014/000426 WO2015081401A1 (pt) | 2013-12-05 | 2014-12-04 | Processo para preparar uma composição anti-helmíntica, composição anti-helmíntica, método de tratamento veterinário e método de tratamento anti-helmíntico |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2016007309A MX2016007309A (es) | 2017-03-09 |
MX370585B true MX370585B (es) | 2019-12-17 |
Family
ID=53272660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016007309A MX370585B (es) | 2013-12-05 | 2014-12-04 | Proceso para preparar una composicion anti-helmintica, composicion anti-helmintica, metodo de tratamiento veterinario y metodo de tratamiento anti-helmintico. |
Country Status (6)
Country | Link |
---|---|
US (1) | US10052341B2 (es) |
AR (1) | AR098630A1 (es) |
AU (1) | AU2014360618A1 (es) |
BR (1) | BR102013031277B1 (es) |
MX (1) | MX370585B (es) |
WO (1) | WO2015081401A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107375205B (zh) * | 2017-07-31 | 2019-11-08 | 佛山市南海东方澳龙制药有限公司 | 非油性多拉菌素注射液及其制备方法和应用 |
CN111920807B (zh) * | 2020-08-24 | 2022-10-04 | 吴蕾 | 阿苯达唑包合物及其超声波法制备工艺 |
BR102020021181A2 (pt) | 2020-10-16 | 2022-04-26 | Ipanema Industria De Produtos Veterinarios Ltda | Microssuspensão contra parasitas e método para sua obtenção |
CN113214163B (zh) * | 2021-04-30 | 2023-03-14 | 青海大学 | 一种阿苯达唑-胆酸衍生物及其制备方法和应用 |
CN114917221A (zh) * | 2022-05-27 | 2022-08-19 | 吉林吉力生物技术研究有限公司 | 一种兽用阿苯哒唑亚砜组合物及其制备方法与应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8362086B2 (en) * | 2005-08-19 | 2013-01-29 | Merial Limited | Long acting injectable formulations |
JP5342239B2 (ja) * | 2005-12-06 | 2013-11-13 | ゾエティス・ダブリュー・エルエルシー | ベンジイミダゾール非水性組成物 |
BRPI0506279B1 (pt) * | 2005-12-16 | 2018-01-09 | Npa - Núcleo De Pesquisas Aplicadas Ltda | Composição sinergística de antihelmínticos e endectocidas |
CN1839864A (zh) * | 2006-01-20 | 2006-10-04 | 长治奥凯得日化有限责任公司 | 复方阿维菌素注射液 |
BRPI0904365A2 (pt) * | 2009-11-05 | 2011-11-16 | Ouro Fino Participacoes E Empreendimentos S A | associações farmacêuticas, composições farmacêuticas, medicamento e método para o tratamento de animais |
AU2011252987B2 (en) * | 2010-05-12 | 2013-05-02 | Boehringer Ingelheim Animal Health USA Inc. | Injectable parasiticidal formulations of levamisole and macrocyclic lactones |
CN102258529B (zh) * | 2011-04-29 | 2013-02-13 | 长沙施比龙动物药业有限公司 | 一种复方伊维菌素注射液及其制备方法 |
CN102440996B (zh) * | 2011-12-29 | 2013-04-24 | 郑国祥 | 含有伊维菌素纳米乳的复方阿苯达唑混悬液及其制备方法 |
-
2013
- 2013-12-05 BR BR102013031277A patent/BR102013031277B1/pt active IP Right Grant
-
2014
- 2014-12-04 US US15/101,910 patent/US10052341B2/en active Active
- 2014-12-04 WO PCT/BR2014/000426 patent/WO2015081401A1/pt active Application Filing
- 2014-12-04 AU AU2014360618A patent/AU2014360618A1/en not_active Abandoned
- 2014-12-04 MX MX2016007309A patent/MX370585B/es active IP Right Grant
- 2014-12-05 AR ARP140104530A patent/AR098630A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
MX2016007309A (es) | 2017-03-09 |
US10052341B2 (en) | 2018-08-21 |
WO2015081401A1 (pt) | 2015-06-11 |
BR102013031277A2 (pt) | 2015-11-10 |
AR098630A1 (es) | 2016-06-01 |
AU2014360618A1 (en) | 2016-07-14 |
BR102013031277B1 (pt) | 2018-10-02 |
US20160303157A1 (en) | 2016-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL264413B (en) | Preparations containing fibers obtained electrohydrodynamically for delivering specific doses of active substance to the skin or mucous membrane | |
CY1121928T1 (el) | Φαρμακευτικη συνθεση υδροχλωρικης s-κεταμινης | |
NZ742208A (en) | Topical pharmaceutical formulations for treating inflammatory-related conditions | |
EA201691988A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
PH12016500582A1 (en) | Heterocyclic compounds and uses thereof | |
MX2016013689A (es) | Compuestos 4-amino-imidazoquinolina. | |
CL2015000543A1 (es) | Derivados de alcanediil y alcanediil-c17, de ácido oleanólico compuestos intermediarios, composición parmacéutica y métodos asociados. | |
NI201600071A (es) | Compuestos de inhibidor de autotaxina | |
CR20160564A (es) | Dinucleótidos cíclicos como moduladores de sting | |
CL2015001389A1 (es) | Composiciones y compuestos antihelmínticos y métodos para usarlos. | |
PH12016500511A1 (en) | Selective grp94 inhibitors and uses thereof | |
UY34750A (es) | ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?. | |
MX2016004035A (es) | Formulaciones de espiro-isoxazolina de accion prolongada. | |
PH12016502003B1 (en) | Novel bacteriophage and composition containing same | |
MX2016007309A (es) | Proceso para preparar una composicion anti-helmintica, composicion anti-helmintica, metodo de tratamiento veterinario y metodo de tratamiento anti-helmintico. | |
NI201600070A (es) | Inhibidores tetracíclicos de autotaxina | |
EA201692043A1 (ru) | Лекарственная форма иммунодепрессанта | |
BR112017000730A2 (pt) | derivados de pirrolidinona como inibidores de metap-2 | |
CL2018001493A1 (es) | Nuevos derivados de fenilo | |
PH12016501999B1 (en) | Novel bacteriophage and composition containing same | |
BR112017008481A2 (pt) | composto antimicótico | |
TN2015000440A1 (en) | Alpha-2 adrenoceptor and sigma receptor ligand combinations | |
PH12016502001B1 (en) | Novel bacteriophage and composition comprising same | |
MX2018005987A (es) | Compuestos heterociclicos para el tratamiento de enfermedades. | |
PE20170770A1 (es) | Metodos y composiciones para tratar trastornos relacionados con vih |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |